Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LBPH

Longboard Pharmaceuticals (LBPH) Stock Price, News & Analysis

Longboard Pharmaceuticals logo

About Longboard Pharmaceuticals Stock (NASDAQ:LBPH)

Advanced Chart

Key Stats

Today's Range
$59.98
$59.98
50-Day Range
$59.50
$59.98
52-Week Range
$27.35
$60.03
Volume
N/A
Average Volume
1.33 million shs
Market Capitalization
$2.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$63.43
Consensus Rating
Hold

Company Overview

Receive LBPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

LBPH Stock News Headlines

H Lundbeck A/S (HLUNAC.XD)
H. Lundbeck A/S (HLUN-A.CO)
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Headlines

LBPH Stock Analysis - Frequently Asked Questions

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) announced its quarterly earnings results on Thursday, August, 1st. The company reported ($0.56) EPS for the quarter, missing analysts' consensus estimates of ($0.46) by $0.10.
Read the conference call transcript
.

Longboard Pharmaceuticals (LBPH) raised $75 million in an IPO on Friday, March 12th 2021. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Citigroup, Evercore ISI, Guggenheim Securities and Cantor acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Longboard Pharmaceuticals investors own include JPMorgan Chase & Co. (JPM), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Visa (V) and Home Depot (HD).

Company Calendar

Last Earnings
8/01/2024
Today
7/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LBPH
CIK
1832168
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$90.00
Low Price Target
$44.00
Potential Upside/Downside
+5.7%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$54.42 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-33.03%
Return on Assets
-30.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.97
Quick Ratio
15.97

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.67 per share
Price / Book
35.92

Miscellaneous

Outstanding Shares
39,050,000
Free Float
37,234,000
Market Cap
$2.34 billion
Optionable
Optionable
Beta
1.00
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:LBPH) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners